Ilex Medical Ltd (TLV:ILX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 7,090.00
-131.00 (-1.81%)
Feb 20, 2025, 5:24 PM IDT
Ilex Medical Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 792 | 663 | 1,081 | 1,834 | 1,388 | 836 | Upgrade
|
| Market Cap Growth | -6.73% | -38.63% | -41.07% | 32.20% | 65.99% | 58.97% | Upgrade
|
| Enterprise Value | 666 | 555 | 926 | 1,705 | 1,341 | 948 | Upgrade
|
| Last Close Price | 70.25 | 57.62 | 91.72 | 150.08 | 108.07 | 73.19 | Upgrade
|
| PE Ratio | 14.34 | 13.04 | 10.58 | 9.29 | 11.50 | 13.87 | Upgrade
|
| PS Ratio | 0.80 | 0.71 | 1.24 | 1.73 | 1.47 | 1.32 | Upgrade
|
| PB Ratio | 1.22 | 1.06 | 1.76 | 3.19 | 3.13 | 2.58 | Upgrade
|
| P/TBV Ratio | 1.17 | 1.11 | 1.86 | 3.34 | 3.37 | 4.50 | Upgrade
|
| P/FCF Ratio | 9.57 | 20.95 | 24.79 | 7.98 | 10.05 | 15.21 | Upgrade
|
| P/OCF Ratio | 6.33 | 8.25 | 15.50 | 6.78 | 7.61 | 9.85 | Upgrade
|
| EV/Sales Ratio | 0.68 | 0.60 | 1.06 | 1.61 | 1.42 | 1.50 | Upgrade
|
| EV/EBITDA Ratio | 6.87 | 5.22 | 5.29 | 5.75 | 7.20 | 8.37 | Upgrade
|
| EV/EBIT Ratio | 10.65 | 7.62 | 6.67 | 6.93 | 9.15 | 12.51 | Upgrade
|
| EV/FCF Ratio | 8.03 | 17.52 | 21.25 | 7.42 | 9.71 | 17.24 | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.08 | 0.08 | 0.10 | 0.15 | 0.30 | Upgrade
|
| Debt / EBITDA Ratio | 0.52 | 0.45 | 0.29 | 0.20 | 0.36 | 0.86 | Upgrade
|
| Debt / FCF Ratio | 0.65 | 1.52 | 1.18 | 0.26 | 0.48 | 1.76 | Upgrade
|
| Asset Turnover | 1.00 | 0.97 | 0.98 | 1.28 | 1.39 | 1.14 | Upgrade
|
| Inventory Turnover | 4.60 | 4.58 | 4.48 | 5.39 | 6.04 | 5.46 | Upgrade
|
| Quick Ratio | 1.58 | 1.86 | 2.11 | 2.12 | 1.49 | 1.57 | Upgrade
|
| Current Ratio | 2.38 | 2.46 | 2.81 | 2.63 | 2.00 | 2.05 | Upgrade
|
| Return on Equity (ROE) | 8.81% | 8.23% | 17.18% | 38.76% | 32.85% | 20.92% | Upgrade
|
| Return on Assets (ROA) | 4.41% | 4.75% | 9.78% | 18.60% | 13.46% | 8.49% | Upgrade
|
| Return on Capital (ROIC) | 6.41% | 6.81% | 13.36% | 26.88% | 19.68% | 12.08% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.64% | 9.88% | 20.62% | 38.77% | 29.30% | 19.30% | Upgrade
|
| Earnings Yield | 6.92% | 7.67% | 9.45% | 10.77% | 8.69% | 7.21% | Upgrade
|
| FCF Yield | 10.45% | 4.77% | 4.03% | 12.52% | 9.95% | 6.58% | Upgrade
|
| Dividend Yield | 1.92% | 2.37% | 2.09% | 3.54% | 4.92% | - | Upgrade
|
| Payout Ratio | 27.85% | 42.14% | 58.75% | 30.38% | - | 41.49% | Upgrade
|
| Buyback Yield / Dilution | 0.25% | 0.79% | 0.02% | -5.73% | -6.33% | - | Upgrade
|
| Total Shareholder Return | 2.17% | 3.16% | 2.11% | -2.18% | -1.41% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.